So if you want a pharmaceutical stock for the long term, 10 years or more, you need to look for companies that continue to ...

And there's more than one way to monetize this technology.

Growth, value, or both?

Natco Pharma shares gained 12% to Rs 918 in the current session against the previous close of Rs 822.10.

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI ...

Torrent Pharma share price jumped as much as 6% in the morning trade on Monday, February 16, to hit a record high of ...

Weight loss drugs are the big story in the pharmaceutical industry today, but other opportunities exist, too. Bristol Myers Squibb isn't focused on weight loss, has an attractive yield, and continues ...

Pharmaceutical companies, by contrast, are using AI as a lever on an existing, already capital-intensive R&D machine. They are not replacing laboratories with algorithms, they are making those ...

With this in mind, let's check out a blastoff-ready biotech stock you'll kick yourself for not buying in 2026. Image source: Getty Images.

Vertex stock has climbed more than 60% over three years.

Ultragenyx Pharmaceuticals reported Phase 3 results for setrusumab, a potential treatment for osteogenesis imperfecta. Several firms have reduced their price targets on Ultragenyx stock. Investors may ...